"Artificial intelligence + healthcare" welcomes new policies, many listed companies are expected to benefit.

On November 4th, the National Health Commission issued the "Implementation Opinions on Promoting and Regulating the Development of 'Artificial Intelligence + Medical Health' Applications". It was noted that a number of A-share companies such as Shanwaishan, Yunnan Baiyao, and Aojiatia have already laid out different industrial tracks for "Artificial Intelligence + Medical Health" early on. The "Implementation Opinions" further clarify the direction of industry support and key application areas, bringing new opportunities for related listed companies to expand their businesses and helping them create new growth points for performance.